Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development
Open Access
- 20 August 2025
- journal article
- gastroenterology and-hepatology
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 11, e66309
Abstract
Background: Chronic hepatitis B (CHB) remains a significant health burden for at least a hundred thousand Canadians. The government of Canada has endorsed the global strategy to eliminate hepatitis as a public health threat by 2030, but effectively targeting public health interventions is complicated by the silent nature of the disease, which can remain asymptomatic for decades. Objective: This study develops a framework to estimate the prevalence of CHB and the proportion of the infected population that remains undiagnosed. We apply the proposed method to national data from Canada, from 2007 to 2021. Methods: We infer the prevalence and undiagnosed proportion of CHB by fitting a mathematical state-transition model, based on the natural history of CHB, to observed CHB-related events. Data for the calibration were obtained from the Public Health Agency of Canada and Statistics Canada. Results: We estimate the national prevalence of CHB in Canada in 2021 to be 0.483% (95% CI 0.443%-0.535%). The corresponding percentage of undiagnosed cases was estimated to be 54.3% (95% CI 50.9%-58.9%). Conclusions: The estimates of CHB prevalence obtained via our method are in line with previous estimates obtained from national seroprevalence studies. More specialized estimates, stratified by province or age cohort, may be achievable with detailed health administrative data.Keywords
All Related Versions
This publication has 11 references indexed in Scilit:
- Estimation of COVID-19 Period Prevalence and the Undiagnosed Population in Canadian Provinces: Model-Based AnalysisJMIR Public Health and Surveillance, 2021
- Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive studyCanadian Medical Association Journal, 2020
- Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over TimeHepatology, 2020
- A model-based framework for chronic hepatitis C prevalence estimationPLOS ONE, 2019
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology, 2018
- Estimated prevalence of Hepatitis C Virus infection in Canada, 2011Canada Communicable Disease Report, 2014
- Seroprevalence of hepatitis B and C virus infections: Results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey.2013
- Cost effectiveness of screening immigrants for hepatitis BLiver International, 2011
- Management of hepatitis B in pregnancy: Weighing the optionsCleveland Clinic Journal of Medicine, 2009
- Estimating the stage‐specific numbers of HIV infection using a markov model and back‐calculationStatistics in Medicine, 1992